Physician profile
Meagan Williams
NPI 1205590791
$3,400.76
in general payments reported to CMS, 2019-2025
20 companies · $33.33 in 2025
The $33.33 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,796 · 2023: $1,061 · 2024: $511 · 2025: $33.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021 · Travel and Lodging: $449 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,020.89 |
| Travel and Lodging | $449.25 |
| Education | $134.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,377.05 | 2022-2024 | Axonics |
| Teleflex LLC | $854.28 | 2022-2024 | Urolift |
| Pfizer INC. | $295.00 | 2022-2024 | |
| Astellas Pharma US INC | $180.20 | 2023-2024 | Myrbetriq, Xtandi |
| Laborie Medical Technologies Corp. | $149.69 | 2023 | |
| Dendreon Pharmaceuticals LLC | $126.12 | 2022-2024 | Provenge |
| Progenics Pharmaceuticals, INC. | $102.18 | 2022-2024 | Pylarify |
| Urogen Pharma, INC. | $53.53 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $43.90 | 2024 | Adstiladrin |
| Endo USA, INC. | $35.83 | 2024 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $32.97 | 2022-2024 | |
| Tolmar, INC. | $22.59 | 2023 | |
| Janssen Biotech, INC. | $21.76 | 2023 | |
| Accord Healthcare, INC. | $17.01 | 2022 | |
| Coloplast Corp | $16.81 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.31 | 2022 | |
| Endo Pharmaceuticals INC. | $14.88 | 2023 | Aveed, Xiaflex |
| Myovant Sciences INC. | $14.45 | 2022 | |
| Abbvie INC. | $13.78 | 2024 | |
| Myriad Genetic Laboratories, INC. | $13.42 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.